Role of iNOS in the vasodilator responses induced by L‐arginine in the middle cerebral artery from normotensive and hypertensive rats

The substrate of nitric oxide synthase (NOS), L‐arginine (L‐Arg, 0.01 μM−1 mM), induced endothelium‐independent relaxations in segments of middle cerebral arteries (MCAs) from normotensive Wistar‐Kyoto (WKY) and hypertensive rats (SHR) precontracted with prostaglandin F2α (PGF2α). These relaxations were higher in SHR than WKY arteries. L‐NG‐nitroarginine methyl ester (L‐NAME) and 2‐amine‐5,6‐dihydro‐6‐methyl‐4H‐1,3‐tiazine (AMT), unspecific and inducible NOS (iNOS) inhibitors, respectively, reduced those relaxations, specially in SHR. Four‐ and seven‐hours incubation with dexamethasone reduced the relaxations in MCAs from WKY and SHR, respectively. Polymyxin B and calphostin C, protein kinase C (PKC) inhibitors, reduced the L‐Arg‐induced relaxation. Lipopolysaccharide (LPS, 7 h incubation) unaltered and inhibited these relaxations in WKY and SHR segments, respectively. LPS antagonized the effect polymyxin B in WKY and potentiated L‐Arg‐induced relaxations in SHR in the presence of polymyxin B. The contraction induced by PGF2α was greater in SHR than WKY arteries. This contraction was potentiated by dexamethasone and polymyxin B although the effect of polymyxin B was higher in SHR segments. LPS reduced that contraction and antagonized dexamethasone‐ and polymyxin B‐induced potentiation, these effects being greater in arteries from SHR. These results suggest that in MCAs: (1) the induction of iNOS participates in the L‐Arg relaxation and modulates the contraction to PGF2α; (2) that induction is partially mediated by a PKC‐dependent mechanism; and (3) the involvement of iNOS in such responses is greater in the hypertensive strain. British Journal of Pharmacology (1999) 126, 111–120; doi:10.1038/sj.bjp.0702281